Showing results (141-150 of 3,768) with videos related to

Sort By:
Pageof 377
The Journal of Pharmacology and Experimental Therapeutics|September 22, 1999
Role of adenosine A(1) receptors in modulating extracellular adenosine levelsB T Andresen, D G Gillespie, Z Mi, et al.
Circulation|January 11, 1991
Reduction of myocardial reperfusion injury by intravenous adenosine administered during the early reperfusion periodC J Pitarys, R Virmani, H D Vildibill, et al.
The Journal of Pharmacology and Experimental Therapeutics|September 22, 1999
Low-dose angiotensin II reduces urinary cyclic AMP excretion in spontaneously hypertensive, but not normotensive, rats: independence from hypertension and renal hemodynamic effects of angiotensinE K Jackson, W A Herzer, Z Mi, et al.
Hypertension (Dallas, Tex. : 1979)|March 7, 2001
A(2b) receptors mediate the antimitogenic effects of adenosine in cardiac fibroblastsR K Dubey, D G Gillespie, L C Zacharia, et al.
Journal of Cardiovascular Pharmacology|January 22, 1998
Phosphodiesterases in the rat renal vasculatureE K Jackson, Z Mi, J A Carcillo, et al.
The Journal of Pharmacology and Experimental Therapeutics|December 1, 1996
Injured erythrocytes release adenosine deaminase into the circulationE K Jackson, Z Mi, M T Koehler, et al.
The American Journal of Medicine|September 1, 1983
Amphotericin B nephrotoxicity in humans decreased by salt repletionH T Heidemann, J F Gerkens, W A Spickard, et al.
Clinical and Experimental Hypertension (New York, N.Y. : 1993)|April 1, 2000
Persistent improvement of cardiovascular risk factors in spontaneously hypertensive rats following early short-term captopril treatmentC K Kost, B R Rominski, W A Herzer, et al.
Anesthesiology|February 1, 1990
The effect of halothane on morphine disposition: relative contributions of the liver and kidney to morphine glucuronidation in the dogW J Merrell, L Gordon, A J Wood, et al.
The Journal of Pharmacology and Experimental Therapeutics|April 1, 1982
Assessment of the extent to exogenous prostaglandin I2 is converted to 6-keto-prostaglandin E1 in human subjectsE K Jackson, R P Goodman, G A Fitzgerald, et al.
Pageof 377